4.6 Article

IL-21 and IL-21 Receptor Expression in Lymphocytes and Neurons in Multiple Sclerosis Brain

期刊

AMERICAN JOURNAL OF PATHOLOGY
卷 178, 期 2, 页码 794-802

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.ajpath.2010.10.043

关键词

-

资金

  1. Medical Research Council (UK and DK)
  2. European Commission
  3. Neuropromise
  4. Sybilla
  5. Danish MS Society
  6. Lundbeck Foundation
  7. Novo Nordisk
  8. Naomi Brayson Foundation
  9. Ministry of Defence, UK
  10. Deutsche Forschungsgemeinschaft (DFG) [FR1720/1-1]
  11. MRC
  12. DFG [FR1720/3]
  13. Oxford Biomedical Research Centre, part of the UK National Institute for Health Research

向作者/读者索取更多资源

IL-17 producing CD4(+) T cells (Th-17) contribute to the pathogenesis of experimental autoimmune encephalomyelitis and are associated with active disease in multiple sclerosis (MS). In addition to IL-17, Th-17 cells can also express IL-21, IL-22, and IL-6 under Th-17 polarizing conditions (IL-6 and transforming growth factor-beta). In this study we investigated IL-21 and IL-21 receptor (IL-21R) expression in MS lesions by in situ hybridization and immunohistochemistry. We detected strongly IL-21(+) infiltrating cells predominantly in acute but also in chronic active white matter MS lesions in which IL-21 expression was restricted to CD4(+) cells. In contrast, IL-21R was much more broadly distributed on CD4(+), CD19(+), and CD8(+) lymphocytes but not major histocompatibility complex class-II+ macrophages/microglia. Interestingly, in cortical areas we detected both IL-21 and IL-21R expression by neurons. These findings suggest role(s) for IL-21 in both the acute and chronic stages of MS via direct effects on T and B lymphocytes and, demonstrated for the first time, also on neurons. (Am J Pathol 2011, 178:794-802; DOI: 10.1016/j.ajpath.2010.10.043)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据